ERYTECH PHARMA (ERYP.PA)

FR0011471135 - Common Stock

0.801  +0 (+0.25%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
2018
(2018-12-31)
Revenue
6.65M4.18M3.72M5.28M4.45M
Operating Expenses
33.80M60.70M72.55M69.36M48.07M
Research and Development
15.91M40.22M53.35M48.66M33.21M
Selling, General, and Administrative Expenses
13.26M15.10M14.52M16.41M14.07M
Operating Income
-27.15M-56.52M-68.83M-64.07M-43.62M
Interest Income/Expense
4.13M3.28M-1.27M2.46M5.42M
Other Income/Expense
-1.04M-564.00K-3.19M-1.04M-18.00K
Non Recurring Items
24.35MN/AN/AN/AN/A
Income Before Taxes
293.00K-53.80M-73.30M-62.66M-38.22M
Income Tax
521.00K2.00K3.00K-1.00K2.00K
Net Income
-228.00K-53.80M-73.30M-62.66M-38.22M
EBITDA
-22.53M-51.14M-63.84M-59.86M-42.82M
 
Per Share Data
EPS Diluted Total Ops
-0.01-2.27-3.99-3.49-2.13
 
Statistics
Profit Margin
-3.43%-1287.01%-1971.49%-1186.05%-859.55%
Operating Profit Margin
-408.35%-1352.03%-1851.32%-1212.83%-980.91%

All data in EUR

Charts